Schiff bases of Istain: Potential anti-leishmanial agents

Letters in Drug Design and Discovery

Volumn 5, Issue 4, 2008, Pages 243-249

  Khan, Khalid Mohammed ^a   Mughal, Uzma Rasool ^a   Samreen, ^a   Perveen, Shahnaz ^b   Choudhary, Muhammad Iqbal ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b PCSIR LABORATORIES COMPLEX   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2 BROMOPHENYLIMINO) 1H INDOL 2 ONE; 3 (4 BROMOPHENYLIMINO) 1H INDOL 2 ONE; 3 [(2 CHLOROPHENYL)IMINO] 1H INDOL 2 ONE; 3 [(3,4 DICHLOROPHENYL)IMINO] 1H INDOL 2 ONE; 3 [(4 METHAOXYPHENYL)IMINO] 1H INDOL 2 ONE; 3 [(4 METHYLPHENYL)IMINO] 1H INDOL 2 ONE; AMPHOTERICIN B; ANTILEISHMANIAL AGENT; AROMATIC AMINE; ISATIN DERIVATIVE; NYSTATIN; PENTAMIDINE; SCHIFF BASE;

ANTIPROTOZOAL ACTIVITY; ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; IC 50; LEISHMANIASIS; POLYMERIZATION; PRIORITY JOURNAL;

EID: 45249110461     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018008784619915     Document Type: Article

References (48)

1. Tropical Disease Research: Progress 1999-2000; World Health Organization: Geneva, 2001.
2. Olliaro, P. L.; Bryceson, A.D.M. Parasitol. Today, 1993, 9, 323.
3. Soto, J.; Arana, B. A.; Toledo, J.; Rizzo, N.; Vega, J. C.; Diaz, A.; Luz, M. Gutierre-Arboleda, M.; Berman, J. D.; Junge, K.; Engel, J.; Sindermann, H. Clin. Infect. Dis., 2004, 38, 1266.
4. Prasad, R.; Kumar, R.; Jaiswal, B. P.; Singh, U. K. Ind. J. Pediatr., 2004, 71, 143.
5. Sangraula, H.; Sharma, K. K.; Rijal, S.; Dwivedi, S.; Koirala, S. J. Assoc. Physicians India, 2003, 51, 686.
6. Carvalho, P. B.; Arribas, M. A. G.; Ferreira, E. I. Braz. J. Pharm. Sci., 2000, 36, 69.
7. Khan, K. M.; Rasheed, M.; Zia-Ullah; Hayat, S.; Kaukab, F.; Choudhary, M. I.; Atta-ur-Rahman; Perveen, S. Bioorg. Med. Chem., 2003, 11, 1381.
8. Leon, L. L.; Machado, G. M. C.; Carvalho-Paes, L. E.; Grimaldi, G. Jr. Trans. Roy. Soc. Trop. Med. Hyg., 1990, 84, 678.
9. Barral, A.; Pedral-Sampaio, D.; Grimaldi, G. Jr.; Momen, H.; Mc-Mahon-Pratt, D.; Ribeiro de Jesus, A.; Almeida, R.; Badaro, R.; Barral-Neto, M.; Carvalho, E. M.; Johnson, W. D. Jr. Amer. J. Trop. Med. Hyg., 1991, 44, 536.
10. Raht, S.; Trivellin, A.; Imbrunito, T. R.; Tomazela, D. M.; Jesus, M. N.; Marzal, P. C.; Junior, H. F. A.; Tempone, A. G. Quim. Nova., 2003, 26, 550.
11. Mcgregor, A. Lancet, 1998, 351, 575.
12. For a reviews see: a) Ram, V. J.; Nath, M. Curr. Med. Chem., 1996, 3, 303.
13. b) Croft, S. L.; Yardley, Curr. Pharmaceut. Des., 2000, 8, 319.
14. c) Tempone, A. G.; Perez. D.; Rath. S.; Vilarinho. A. L.; Mortara. R. A.; Andrade. Jr. H. F.; J. Antimicrob. Chemotherap., 2004, 54, 60.
15. d)http://www.stanford.edu/class/humbio103/ParaSites2003/Leishman ia/Leish%20treat1.html and references quoted therein.
16. Atta-ur-Rehman.; Ijaz. A. S.; Choudhary. M. I.; Amtul. Z.; Atta-ur-Rehman. J. Chem. Soc. Pak., 1997, 19, 230.
17. Da Silva, J. F. M.; Garden, S. J.; Pinto, A. C. J. Braz. Chem. Soc., 2001, 12, 273 and references quoted therein.
18. Kahveci, B. Molecules, 2005, 10, 376.
19. Mashelkar. U. C.; Rane. D. M. J. Indian Chem., 2005, 44 B, 1937.
20. Bouhfid. R.; Joly. N.; Massoui. M.; Cecchelli. R.; Lequart. V.; Martin. P.; Essassi. El. M. Heterocycles, 2005, 65, 2949.
21. Popp. F. D. J. Heterocycl. Chem., 1984, 21, 1641.
22. Sriram. D.; Bal. T. R.; Yogeeswari. P. J. Pharm. Pharm. Sci., 2005, 8, 565.
23. Abele. E.; Abele. R.; Dzenitis. O.; Lukevics. E. Chem. Heterocycl. Comp., 2003, 39, 3.
24. Pandeya. S. N.; Raja. A.Y. J. Pharm. Pharm. Sci., 2002, 5, 266.
25. Sridhar. S. K.; Saravanan. M.; Ramesh. A. Eur. J. Med. Chem., 2001, 36, 615.
26. Sridhar, S. K.; Ramesh, A. Biol. Pharm. Bull., 2001, 24, 1149.
27. Sandmeyer, T. Helv. Chim. Acta, 1919, 2, 234.
28. Popp, F. D. Adv. Heterocycl. Chem., 1975, 18, 1 and references quoted there in.
29. Sarangapani, M.; Reddy, N. A.; Jayamma, Y.; Reddy, V. M. Indian Drugs, 1998, 35, 336.
30. a) Sarangapani, M.; Reddy, V. M. Indian Drugs, 1999, 36, 357,
31. b) Sarangapani, M.; Reddy, V. M. Indian J. Pharm. Sci., 1996, 58, 147.
32. a) Sarangapani, M.; Reddy, V. M. Indian J. Pharm. Sci., 1997, 59, 105,
33. b) Popp, F. D.; Parson, R.; Donigan, B. E. J. Heterocycl. Chem., 1980, 17, 1329,
34. c) Popp, F. D.; Parson, R.; Donigan, B. E. J. Pharm. Sci., 1980, 69, 1235,
35. d) Pajouhesh, H.; Parson, R.; Popp, F. D. J. Pharm. Sci., 1983, 72, 318
36. e) Popp, F. D.; Pajouhesh, H. J. Pharm. Sci., 1982, 71, 1052
37. f) Bhattacharya, S. K. Indian J. Exp. Biol., 1998, 36, 118.
38. Singh, G. S.; Singh, T.; Lakhan, R. Indian J. Chem., 1997, 36B, 951.
39. a) Lingaiah, N.; Narendra, R.; Dattatray, A. M. Indian J. Chem., 1998, 37B, 1254
40. b) Andreani, A.; Maselli, Bull. Chim. Farm., 1977, 116, 493.
41. Medvedec, A. E.; Clow, A. Sandler, M.; Glover, V. Biochem. Pharmacol., 1998, 52, 385,
42. b) Glover, V.; Halket, J. M.; Watkins, P. J.; Clone A.; Goodwin, B.; Sandler, A. J. Neurochem., 1998, 51, 656.
43. Panova, N. G.; Zemskova, M. A.; Axenova, L. N.; Medevedev, A. E. Neurosci. Lett., 1997, 223, 58.
44. Jarrahpour, A. A; Khalili, D.; Clercq, E. De.; Salmi, C.; Brunel, J. M. Molecules, 2007, 12, 1720.
45. Krishna, C. J.; Rahul. J. J. Indian Chem. Soc., 1999, 76, 643
46. Verma, M.; Pandeya, S. N.; Singh, K. N.; Stables, J. P. Acta Pharm., 2004, 54, 49.
47. Jarrahpour, A. A.; Khalili, D. Molecules, 2006, 11, 59.
48. Atta-ur-Rahman; Choudhary, M. I.; Thomsen, W. J., Bioassay Techniques for Drug Developement; Harwood Academic Publisher: The Netherlands, 2001, pp. 60-64